Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patie...

by Andrew R. Moore, Malcolm Boyce, Islay A. Steele, Fiona Campbell, Andrea Varro, D. Mark Pritchard
Published 2013-01-01

Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chr...

by Andrew R Moore, Malcolm Boyce, Islay A Steele, Fiona Campbell, Andrea Varro, D Mark Pritchard
Published 2013-01-01

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patie...

by Andrew R. Moore, Malcolm Boyce, Islay A. Steele, Fiona Campbell, Andrea Varro, D. Mark Pritchard
Published 2013-01-01